KRAS and colorectal carcinoma: Interestingly, patients with Lynch syndrome-associated CRC, representing only 2–3% of all CRC patients, are also found to have a higher frequency of KRAS mutation, yet they generally show a favourable clinical outcome (Oliveira et al, 2007; Green et al, 2009).